AzTrials
AzTrials

Critical IllnessPhase 2REVIVENCT01463579

Exercise After Intensive Care Unit: a Randomised Controlled Trial

A Phase 2 study testing Exercise Programme in people with Critical Illness and Intensive Care, run by University of Ulster at 5 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test if a 6-week programme of exercise improves physical function and health related quality of life in patients following intensive care who are discharged from hospital. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness, Intensive Care
What is being tested?
Exercise Programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
5 sitesUnited Kingdom
Study dates
Dec 2011to Apr 2015
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age ≥ 18 years
  • ICU admission requiring mechanical ventilation > 96 hours
  • planned discharge to home (self-care/carer)
  • willing and able to participate in exercise
  • deemed medically fit to take part in the intervention

Who cannot join

  • declined consent or unable to give consent
  • inability to participate due to e.g. any neurological, spinal or skeletal dysfunction affecting ability to exercise
  • cognitive impairment affecting ability to understand the intervention or complete questionnaires
  • participation in another rehabilitation programme due to ongoing chronic disease
  • other medical contraindication to participation in an exercise programme

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United Kingdom5 sites
  • Northern Health and Social Care Trust

    Antrim, Co. Antrim, BT41 2RL

  • Belfast Health and Social Care Trust

    Belfast, Co. Antrim, BT12 6BA

  • Southern Health and Social Care Trust

    Craigavon, Co. Armagh, BT63 5QQ

  • South Eastern Health and Social Care Trust

    Dundonald, Co Down, BT16 1RH

  • Western Health and Social Care Trust

    Londonderry, Co. Londonderry, BT47 6SB

Other trials in United Kingdom

About this study

Official title: Effectiveness of a Programme of Exercise on Physical Function in Survivors of Critical Illness Following Discharge From the Intensive Care Unit (ICU): a Randomised Controlled Trial

The purpose of this study is to test if a 6-week programme of exercise improves physical function and health related quality of life in patients following intensive care who are discharged from hospital. In this study the investigators will compare the physical function and health related quality of life of patients who attend the programme with patients who do not. The 6 week exercise programme will be run by physiotherapy staff, and will mostly take place in a hospital gym. The investigators will measure patients' physical function, exercise capacity, level of breathlessness and their quality of life before and after the 6-week programme, and 6 months later. The investigators will also interview patients to ask their views about the acceptability, enjoyment and satisfaction with the exercise programme. If this study shows that the physical function and health related quality of life are improved in those who took part in the exercise programme, then it will provide useful information which will help the development of services for patients after critical illness. The results will also provide information which will help us design future clinical trials for this patient population.

Read the detailed description

Most critically ill adult patients require ventilatory support during their intensive care unit stay. Following discharge home patients often still suffer from reduced physical function, exercise capacity, health related quality of life and social functioning for at least 2 years. There is usually no support to address these longer term problems specific to critical illness for patients after hospital discharge. Little research has been carried out into interventions which could improve physical function and quality of life, or enhance speed of recovery in these patients. While there is evidence to support the rehabilitation of critically ill patients within intensive care units, there is a paucity of literature to support rehabilitation following discharge from intensive care and hospital. Therefore, there is a clear and urgent need to investigate interventions which could improve the recovery of patients discharged home after intensive care. This is emerging as a prominent therapeutic objective for the future for this population.

This study will investigate whether a programme of exercise following discharge from hospital will improve outcome in patients following critical illness compared to standard care.

Being tested
Exercise Programme, Standard Care
Keywords
Intensive Care Unit, Critical Illness, Rehabilitation, Exercise Programme
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise ProgrammeOther

    Patients will complete three exercise sessions per week (2 supervised and 1 unsupervised) for 6 weeks. They will receive a written exercise manual which facilitates completion of their exercise programme. The exercise programme will consist of a warm-up, an exercise circuit, a period of aerobic exercise, and a cool down. The programme will be tailored to each patient's ability and needs.

    At the end of the 6 weeks patients will receive a short consultation to set goals relating to continuing exercise at home.

  • Standard CareOther

    Following ICU admission patients are discharged to hospital wards to the care of a consultant, and the patients are no longer under the care of the ICU team. They are provided with appropriate medical and nursing care, and with referral to other disciplines as necessary. One mobile and able to return home to a carer or another facility they are discharged from hospital. There is usually no support to address potential problems specific to critical illness for patients after ICU discharge.

Study groups in NCT01463579
Study groupRoleWhat they receive
Exercise programmeExperimentalNot described
Receives: Other: Exercise Programme
Standard CareOtherNot described
Receives: Other: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Functioning subscale of the SF-36

    The primary outcome measure will be physical function as measured by the physical functioning (PF) subscale of the SF-36v2 following the exercise programme. This is an important outcome that is meaningful to patients. This has been shown to be an acceptable, reliable and valid tool following critical illness.

    Measured: 6 weeks

Secondary outcomes (14)
  1. Physical Functioning Subscale of the SF-36

    Measured: 6 months

  2. Rivermead Mobility Index

    Physical Function will also be measured using the Rivermead Mobility Index.

    Measured: 6 weeks, 6 months

  3. Hand Dynamometry

    Patients have indicated to us that hand function is particularly slow to return after critical illness and that this is important to them. Strength and dexterity will specifically be measured by dynamometry and the Nine Hole Peg Test.

    Measured: 6 weeks, 6 months

  4. The Nine Hole Peg Test

    Patients have indicated to us that hand function is particularly slow to return after critical illness and that this is important to them. Strength and dexterity will specifically be measured by dynamometry and the Nine Hole Peg Test.

    Measured: 6 weeks, 6 months

  5. Incremental Shuttle Walk Test

    Exercise capacity will be measured with the Incremental Shuttle Walk Test (ISWT). This is a valid and standardised test of exercise capacity which is responsive to exercise based interventions in other populations. Furthermore the ISWT was used in our pilot study and demonstrated the feasibility and responsiveness of this measure.

    Measured: 6 weeks, 6 months

  6. Functional Limitations Profile

    Health related quality of life (HRQoL) will also be measured using Functional Limitations Profile (FLP) questionnaire. The FLP questionnaire is a well validated and widely used generic instrument to measure health status in a variety of conditions including critical illness. It provides an estimate of sickness related dysfunction and has both physical and psychosocial dimensions. It was used in our pilot study.

    Measured: 6 weeks, 6 months

  7. other subscales of the SF-36

    Health Related Quality of Life (HRQoL) is also assessed using other subscales of the SF-36v2, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Scores are provided for each of these health domains, and two summary measures of physical and mental health: the Physical Component Summary (PCS) and Mental Component Summary (MCS).

    Measured: 6 weeks, 6 months

  8. Hospital Anxiety and Depression Scale

    Anxiety and depression function will be measured using the Hospital Anxiety and Depression Scale (HADS). The HADS contains 14 statements and scores from 0-21. Scores of 8-10 indicate the possibility of anxiety or depression, and 11 and above indicate that these are likely to be present. It has been validated in the critical care population.

    Measured: 6 weeks, 6 months

  9. 'Readiness to change' questionnaire

    Patient's readiness to exercise and self efficacy to exercise are important aspects of feasibility when commencing an exercise programme. Readiness to commence exercise following critical illness will be obtained by assessing components relating to the transtheoretical model (stages, processes, decisional balance, self-efficacy). There is evidence of reliability and validity of the questionnaires designed to measure these constructs.

    Measured: 6 weeks, 6 months

  10. Chronic Disease Self Efficacy Scale (Exercise component)

    The exercise component of the Chronic Disease Self Efficacy Scale will be used to measure self efficacy relating to exercise.

    Measured: 6 weeks, 6 months

  11. The EuroQol-5D

    The EuroQol-5D is a useful measure of health related quality of life in a mixed critical care population.

    Measured: 6 weeks, 6 months

  12. Medical Research Council Dyspnoea Scale

    Breathlessness will be measured by the Medical Research Council dyspnoea scale. Breathlessness is a common problem encountered by these patients and an important patient focused outcome.

    Measured: 6 weeks, 6 months

  13. 'Healthcare Utilisation' Questionnaire

    Measured: 6 months

  14. Semi-structured Interview

    Patient's perceptions of the exercise programme will be explored.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2011 (estimated)
  2. Study startDec 2011
  3. Primary completionFeb 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01463579
Sponsor's protocol ID
11/0291
Acronym
REVIVE
Status last verified
Dec 2015
First submitted
8 Sep 2011
Last updated
14 Dec 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • O'Neill B, McDowell K, Bradley J, Blackwood B, Mullan B, Lavery G, Agus A, Murphy S, Gardner E, McAuley DF. Effectiveness of a programme of exercise on physical function in survivors of critical illness following discharge from the ICU: study protocol for a randomised controlled trial (REVIVE). Trials. 2014 Apr 27;15:146. doi: 10.1186/1745-6215-15-146.

    PubMed 24767671
  • McDowell K, O'Neill B, Blackwood B, Clarke C, Gardner E, Johnston P, Kelly M, McCaffrey J, Mullan B, Murphy S, Trinder TJ, Lavery G, McAuley DF, Bradley JM. Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial). Thorax. 2017 Jul;72(7):594-595. doi: 10.1136/thoraxjnl-2016-208723. Epub 2016 Nov 15.

    PubMed 27852953

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Exercise Programme in people with Critical Illness and Intensive Care, run by University of Ulster at 5 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Functioning subscale of the SF-36 (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01463579, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in